ROME, July 16 (Reuters) - Angelini Pharma said on Thursday it had completed the acquisition of U.S. rare-disease drug maker Catalyst Pharmaceuticals in a $4.1 billion deal involving Italian state ...
Catalyst Pharmaceuticals (NASDAQ:CPRX) stockholders approved the company’s proposed merger with Angelini Pharma S.p.A. at a ...
The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain ...
Funding will support nationwide expansion of Handspring's clinician-led, evidence-based care model and technology platform for pediatric mental ...
- The collaboration agreement combines Angelini Pharma’s expertise in neurological diseases with JCR Pharmaceuticals’ scientific and technological excellence to deliver biotherapeutics across the ...
ROME, May 11 (Reuters) - Family-owned Italian industrial conglomerate Angelini is set to invest up to $505.5 million to fund development of a new treatment for epilepsy by Japan's JCR Pharmaceuticals ...
MILAN — Give Back Beauty, or GBB, has inked an agreement with Italian giant Angelini Industries to take over its beauty division AB Parfums SpA, formerly known as Angelini Beauty. Financial details ...
The longtime power lunch favorite on Beverly Boulevard embraces a new community by the sea with fans including Chris Pine. By Evan Nicole Brown Culture Writer Angelini Osteria, a longtime Hollywood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results